Clinical Trial Update: Menstrual Blood Stem Cells in Poor Ovarian Responders [Phase 3]

View source ↗

Summary

Phase 3 trial update on menstrual blood–derived stem cells for poor ovarian responders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Poor Ovarian Response

Snippet

Sponsor: Avicenna Research Institute | Conditions: Poor Ovarian Response, Infertility, Female | Phase 3 | Status: COMPLETED